Clinical Trials
Page 8 • 8 itemsAccess global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Medicenna's Bizaxofusp Shows Promise in Brain Cancer Trials Ahead of 2026 Investor Conference
Medicenna's bizaxofusp demonstrates clinical progress in glioblastoma trials with FDA FastTrack status, positioning for major investor presentation in 2026.
Grace Therapeutics GTx-104 Phase 3 STRIVE-ON Trial Results Accepted for AAN 2026 Presentation
Grace Therapeutics announces STRIVE-ON Phase 3 safety trial results for GTx-104 injectable nimodipine accepted for AAN 2026 presentation.
New Clinical Trial Monitoring Course Addresses Rising GCP Compliance Issues in Biopharmaceutical Industry
Online GCP compliance course launches June 2026 to address increasing regulatory inspection findings in clinical trial monitoring across biopharma and CROs.
New GCP Inspections Training Course Addresses ICH GCP E6(R3) and EU CTR Compliance for Pharmaceutical Companies
ResearchAndMarkets.com announces comprehensive GCP inspections training covering EU, FDA, and MHRA expectations under updated ICH GCP E6(R3) guidelines.
GlycoNex GNX1021 Gets PMDA Approval for First-in-Human Phase 1 Trial in Gastrointestinal Cancers
GlycoNex receives PMDA approval to begin first-in-human Phase 1 trial of GNX1021 antibody-drug conjugate for advanced gastrointestinal cancers in Japan.
EU Clinical Trials Regulation 2026: Impact on Rare Disease Drug Development
The EU Clinical Trials Regulation 2026 aims to streamline processes, significantly influencing the development of drugs for rare diseases such as Duchenne Muscular Dystrophy.
AI-Powered Clinical Trial Matching: Transforming Patient Recruitment in the EU
AI-powered clinical trial matching is transforming patient recruitment in the EU, streamlining access to groundbreaking treatments for chronic diseases.
EMA Releases Landmark Guidelines on AI Use in Clinical Trials
The EMA has unveiled landmark guidelines on the use of AI in clinical trials, paving the way for improved drug development and patient outcomes.